Caris Life Sciences Raises 2025 Revenue Guidance After Strong Q3 Results
Caris Life Sciences reported third-quarter 2025 revenue of $216.8 million, a 113% increase from the same period last year, announced in a press release. The company attributed the growth to strong performance in its molecular profiling services.
Caris completed 50,763 clinical therapy selection cases during the quarter, marking an 18.2% increase year-over-year. Gross margin improved to 68.0%, representing a 2,432 basis point increase from the prior year period.
The company reported a net income of $24.3 million and positive adjusted EBITDA of $51.2 million. Operating activities generated $62.4 million in net cash flow, with free cash flow reaching $55.3 million.
Based on its performance, Caris raised its full-year 2025 revenue guidance to a range of $720 million to $730 million, representing expected growth of 75% to 77% compared to 2024.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
SOPHiA GENETICS revenue rises 25% to $24.3 million
Araceli Biosciences Adds Investor to $4.5 Million Round
BigBear.ai Revenue Rises 31% and 2026 Guidance Increases
Cerebras posts record revenue, discloses Microsoft cloud deal and expects to triple sales in 2027
Cisco now expects $9 billion in hyperscaler AI infrastructure revenue this fiscal year
Daily AI Brief: the AI news that matters, in your inbox.